Manorcare Health Services Boynton Beach | |
3001 South Congress Avenue, Boynton Beach, Florida 33426 | |
(561) 737-5600 | |
Name | Manorcare Health Services Boynton Beach |
---|---|
Location | 3001 South Congress Avenue, Boynton Beach, Florida |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 180 |
Occupancy Rate | 68.67% |
Medicare ID (CCN) | 105496 |
Legal Business Name | Manor Care Of Boynton Beach Fl Llc |
Ownership Type | Non Profit - Other |
NPI Number | 1114973393 |
Organization Name | MANOR CARE OF BOYNTON BEACH FL LLC |
Doing Business As | PROMEDICA SKILLED NURSING AND REHABILITATION (BOYNTON BEACH SOUTH) |
Address | 3001 S Congress Ave, Boynton Beach, FL 33426 |
Phone Number | 561-737-5600 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
A new report from researchers at the Johns Hopkins Bloomberg School of Public Health offers recommendations aimed at federal, state, and local policymakers to address the opioid epidemic during the pandemic, which has seen sharp increases in fatal and nonfatal overdoses.
Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals - Clinical Gastroenterology and Hepatology and Gastroenterology - highlight important updates into treatments for these two debilitating diseases.
Working with human brain tissue samples and genetically engineered mice, Johns Hopkins Medicine researchers together with colleagues at the National Institutes of Health, the University of California San Diego Shiley-Marcos Alzheimer's Disease Research Center, Columbia University, and the Institute for Basic Research in Staten Island say that consequences of low levels of the protein NPTX2 in the brains of people with Alzheimer's disease (AD) may change the pattern of neural activity in ways that lead to the learning and memory loss that are hallmarks of the disease.
First study to show that among men with no previous history of coronary artery disease, gout is a significant independent risk factor of heart attack.
› Verified 7 days ago
NPI Number | 1841902467 |
Organization Name | BOYNTON OPCO LLC |
Address | 3001 S Congress Ave, Boynton Beach, FL 33426 |
Phone Number | 561-737-5600 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
A new report from researchers at the Johns Hopkins Bloomberg School of Public Health offers recommendations aimed at federal, state, and local policymakers to address the opioid epidemic during the pandemic, which has seen sharp increases in fatal and nonfatal overdoses.
Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals - Clinical Gastroenterology and Hepatology and Gastroenterology - highlight important updates into treatments for these two debilitating diseases.
Working with human brain tissue samples and genetically engineered mice, Johns Hopkins Medicine researchers together with colleagues at the National Institutes of Health, the University of California San Diego Shiley-Marcos Alzheimer's Disease Research Center, Columbia University, and the Institute for Basic Research in Staten Island say that consequences of low levels of the protein NPTX2 in the brains of people with Alzheimer's disease (AD) may change the pattern of neural activity in ways that lead to the learning and memory loss that are hallmarks of the disease.
First study to show that among men with no previous history of coronary artery disease, gout is a significant independent risk factor of heart attack.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
A new report from researchers at the Johns Hopkins Bloomberg School of Public Health offers recommendations aimed at federal, state, and local policymakers to address the opioid epidemic during the pandemic, which has seen sharp increases in fatal and nonfatal overdoses.
Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals - Clinical Gastroenterology and Hepatology and Gastroenterology - highlight important updates into treatments for these two debilitating diseases.
Working with human brain tissue samples and genetically engineered mice, Johns Hopkins Medicine researchers together with colleagues at the National Institutes of Health, the University of California San Diego Shiley-Marcos Alzheimer's Disease Research Center, Columbia University, and the Institute for Basic Research in Staten Island say that consequences of low levels of the protein NPTX2 in the brains of people with Alzheimer's disease (AD) may change the pattern of neural activity in ways that lead to the learning and memory loss that are hallmarks of the disease.
First study to show that among men with no previous history of coronary artery disease, gout is a significant independent risk factor of heart attack.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.83 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.28 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 72.44 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.64 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.51 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.28 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 5.41 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.97 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 29.37 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.47 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 6.51 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 45.41 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.99 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 11.39 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 84.92 | 95.98 |
Percentage of short-stay residents who made improvements in function | 68.18 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.08 | 82.93 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
A new report from researchers at the Johns Hopkins Bloomberg School of Public Health offers recommendations aimed at federal, state, and local policymakers to address the opioid epidemic during the pandemic, which has seen sharp increases in fatal and nonfatal overdoses.
Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals - Clinical Gastroenterology and Hepatology and Gastroenterology - highlight important updates into treatments for these two debilitating diseases.
Working with human brain tissue samples and genetically engineered mice, Johns Hopkins Medicine researchers together with colleagues at the National Institutes of Health, the University of California San Diego Shiley-Marcos Alzheimer's Disease Research Center, Columbia University, and the Institute for Basic Research in Staten Island say that consequences of low levels of the protein NPTX2 in the brains of people with Alzheimer's disease (AD) may change the pattern of neural activity in ways that lead to the learning and memory loss that are hallmarks of the disease.
First study to show that among men with no previous history of coronary artery disease, gout is a significant independent risk factor of heart attack.
› Verified 7 days ago
Boulevard Rehabilitation Center Location: 2839 S Seacrest Blvd, Boynton Beach, Florida 33435 Phone: (561) 732-2464 | |
Ventura Health And Rehabilitation Center Location: 7900 Venture Center Way, Boynton Beach, Florida 33437 Phone: (561) 736-6000 | |
Manorcare Health Services Boynton Beach Location: 3001 South Congress Avenue, Boynton Beach, Florida 33426 Phone: (561) 737-5600 | |
Heartland Health Care Center Boynton Beach Location: 3600 Old Boynton Road, Boynton Beach, Florida 33436 Phone: (561) 736-9992 | |
Boynton Beach Rehabilitation Center Location: 9600 Lawrence Rd, Boynton Beach, Florida 33436 Phone: (561) 740-4100 | |
Barrington Terrace Of Boynton Beach Location: 1425 S Congress Ave, Boynton Beach, Florida 33426 Phone: (561) 369-7919 |